Development of a novel 4-protein signature for prognostic prediction in hepatitis B virus-induced hepatocellular carcinoma
Our study establishes a novel 4-protein signature and nomogram for predicting OS in HBV-related HCC, potentially aiding individualized clinical treatment decisions.
Authors
- Yuhong Zhao (ORCID: https://orcid.org/0000-0002-6806-521X)
- Xiaohui Luo (ORCID: https://orcid.org/0000-0001-9801-5099)
- Heran Zhou (ORCID: https://orcid.org/0009-0002-2519-2654)
- Haifeng Xie
- Pengcheng Tong
Institutions
- Zhejiang Chinese Medical University (CN)
- Hangzhou Hospital of Traditional Chinese Medicine (CN)
- First Affiliated Hospital Zhejiang University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1007/s12672-025-03693-8
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Zhejiang Chinese Medical University